About This Event
Mineralys Therapeutics, Inc. (Nasdaq: MLYS), a clinical-stage biopharmaceutical company focused on developing medicines to target diseases driven by abnormally elevated aldosterone, visits the Nasdaq MarketSite in Times Square. In honor of the occasion, Jon Congleton, CEO of Mineralys, rings the Closing Bell.